Articles and posts

This page contains articles and posts from 2018 to 2024.

Neola Medical receives an award during this year’s NOME Annual Meeting in Copenhagen

Neola Medical receives an award during this year’s NOME Annual Meeting in Copenhagen

November 10, 2023 | News

CEO Hanna Sjöström comments on the Q3 report 2023 in Nyhetsbyrån Direkt

CEO Hanna Sjöström comments on the Q3 report 2023 in Nyhetsbyrån Direkt

November 9, 2023 | News

Neola Medical Q3 report 2023 – Doors open in the U.S. with Stanford support and new strong final results from independent clinical trial in newborns

Neola Medical Q3 report 2023 – Doors open in the U.S. with Stanford support and new strong final results from independent clinical trial in newborns

November 9, 2023 | News, Regulatory

Neola Medical invites to presentation of the Q3-report 2023

Neola Medical invites to presentation of the Q3-report 2023

November 2, 2023 | News, Non regulatory

The business newspaper Rapidus draws attention to Neola Medical’s support from Stanford

The business newspaper Rapidus draws attention to Neola Medical’s support from Stanford

October 24, 2023 | News

Rebel Bites podcast invites Neola Medical’s CEO Hanna Sjöström

Rebel Bites podcast invites Neola Medical’s CEO Hanna Sjöström

October 23, 2023 | News

Nyhetsbyrån Direct in live interview with CEO Hanna Sjöström

Nyhetsbyrån Direct in live interview with CEO Hanna Sjöström

October 19, 2023 | News

CEO Hanna Sjöström participates in this year’s Stanford Impact1 CEO Summit

CEO Hanna Sjöström participates in this year’s Stanford Impact1 CEO Summit

October 18, 2023 | News

BioStock interviews CEO Hanna Sjöström directly from Palo Alto, USA, to hear more about the latest clinical study results and the support from Stanford

BioStock interviews CEO Hanna Sjöström directly from Palo Alto, USA, to hear more about the latest clinical study results and the support from Stanford

October 16, 2023 | News

Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1

Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1

October 12, 2023 | News, Non regulatory

New successful results from clinical study on 100 newborn babies with Neola Medical’s medical device

New successful results from clinical study on 100 newborn babies with Neola Medical’s medical device

October 10, 2023 | News, Non regulatory

Captivating investor presentation at the Redeye Medtech Seminar 2023

Captivating investor presentation at the Redeye Medtech Seminar 2023

September 28, 2023 | News, Presentations

Subscribe

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in Neola Medical

Join our journey